Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20+
SponsorNational Taiwan University Hospital
About this trial
The purpose of the registry is to collect data on the performance of the focused ultrasound (FUS) technology and health outcomes. A wide variety of approaches exist for using FUS on pancreatic cancer patients, and the primary goal is to capture this broad spectrum of approaches and their impact on patients overall health. This information will help provide a better understanding of current care, and may possibly direct further, more specific investigations that will follow this registry.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
20 years and older
Provision of signed and dated informed consent form
Stated willingness to comply with all registry procedures and availability for the duration of the registry
Histology proven pancreatic carcinoma in any area of pancreas
Disqualifiers
Any disease, condition or surgery which would result in a contraindication to undergoing FUS therapy.
Clinical trials of pancreatic cancer not of focused ultrasound or related activities
Trial population
The registry will be implemented at approximately 10 sites internationally. In order to achieve the target registry population of 30 participants over 12 months in the NTUH site, participants who receive focused ultrasound for pancreatic cancer. Participant enrollment will be evaluated on a site by site basis throughout the enrollment period to provide diversity of participant and system representation.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Pain related to pancreatic cancer
Brief Pain Inventory from 0 (no pain) to 10 (pain as a bad as can imagine)
Time frame
after high focused ultrasound treatment, an average of 1 month2
To observe the efficacy of local tumor ablation
the assessment of the tumor burden after high focused ultrasound treatment
Time frame
after high focused ultrasound treatment, an average of 1 month3
The effect of local tumor ablation
time-to-progression
Time frame
over 12 months4
To observe the survival rate
overall survival (OS)
Time frame
over 12 monthsOther outcomes
1
Impact on Quality of Life and Cost
Standardized instrument to measure of health-related quality of life.
Time frame
over 12 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: